Lupus can affect any part of the body, including the bones and bone tissue. New research reviewed bone fracture rates within Medicaid 2007-2010 in people with systemic lupus erythematosus (SLE), lupus nephritis (LN) and non-SLE.
Study Identifies Potential New Targets for Improving Heart Health in People with Lupus
People with lupus and rheumatoid arthritis (RA) have a greater risk of developing cardiovascular diseases (CVD) and atherosclerosis. A new study conducted in Columbia has identified potential new therapeutic targets for reducing endothelial damage (defined as the destruction of the membrane that lines the inside of the heart and blood vessels).
Kidney transplant boosts survival in lupus nephritis
Patients with LN-ESRD have high mortality rates, Dr. April Jorge of Massachusetts General Hospital in Boston, MA, noted in an email to Reuters Health.
"We found that among nearly all such patients in the US who were waitlisted, renal transplant was associated with a significant survival benefit," she said. "This is an encouraging finding, and clinicians should consider early referral for renal transplantation for patients with LN-ESRD who may be candidates, as this can reduce mortality."
Asthma Drug Explored in SLE
Resunab, a promising future treatment for lupus.
Patent holder Corbus Pharmaceuticals is putting the drug, branded Resunab, through its clinical paces.
Ajulemic acid (AJA, CT‐3, IP‐751, JBT‐101, anabasum) is a first‐in‐class, synthetic, orally active, cannabinoid‐derived drug that preferentially binds to the CB2 receptor and is non psychoactive.
In preclinical studies, and in Phase 1 and 2 clinical trials, AJA showed a favorable safety, tolerability, and pharmacokinetic profile. It also demonstrated significant efficacy in preclinical models of inflammation and fibrosis.
Study Shows Rituximab May Be Effective at Treating Cutaneous Lupus Erythematosus
Study Identifies Largest Contributors to Fatigue Among People with Systemic Lupus
Promising Screening Tools Assessed for Cognitive Dysfunction in SLE
The Montreal Cognitive Assessment (MoCA) questionnaire is an easy-to-administer, inexpensive, effective screening tool that can identify patients with systemic lupus erythematosus (SLE) who might be at risk for cognitive dysfunction (CD) and might benefit from additional neuropsychiatric assessment, according to data published in Lupus.
Starchy food may reduce autoimmune reactions in people with lupus
Dental hygiene may be key for lupus
Good oral hygiene prevents cavities. Now, new research suggests it also may make a difference in preventing and managing lupus and other diseases.
Oklahoma Medical Research Foundation scientists Umesh Deshmukh and Harini Bagavant have found a link between gum disease and lupus, an autoimmune disease.
Women who experienced childhood abuse at higher risk for lupus
Recurrent lupus nephritis less frequent after kidney transplant
Lupus nephritis is recurring less frequently among patients with end-stage renal disease who undergo kidney transplant, possibly due to improved immunosuppression, according to data presented by Debendra N. Pattanaik, MBBS, MD, of the University of Tennessee Health Science Center.Lupus nephritis is recurring less frequently among patients with end-stage renal disease who undergo kidney transplant, possibly due to improved immunosuppression, according to data presented by Debendra N. Pattanaik, MBBS, MD, of the University of Tennessee Health Science Center.
Teenage Obesity Increases Lupus Risk
Lupus patients benefited from bioelectronic medicine treatment
A pilot clinical trial showed that bioelectronic medicine treatment was effective in reducing fatigue and pain in lupus patients. The researchers also saw a decrease in arthritis. A pilot study is a small-scale preliminary study that examines the feasibility of an approach that researchers intend to use in a larger scale study.
Hemogenyx teams up with Johnson & Johnson to develop new lupus treatment
Clues to autoimmune origins of lupus in precursor cells
Organs are not just bystanders, may be active participants in fighting autoimmune disease
Organs affected by autoimmune disease could be fighting back by "exhausting" immune cells that cause damage using methods similar to those used by cancer cells to escape detection, according to a study by researchers at the University of Pittsburgh School of Medicine published today in the Journal of Clinical Investigation.
